Home › Atrial Fibrillation › Michigan › Grand Rapids
Atrial Fibrillation clinical trials in Grand Rapids, MI
5 studies for Atrial Fibrillation are looking for participants at sites in and around Grand Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
RecruitingPhase 3
- Corewell Health (Former Spectrum Health), Grand Rapids
- Trinity Health Grand Rapids/Mercy Health, Grand Rapids
BoxX-NoAF Clinical Trial
RecruitingHealthy volunteers welcome
- Corewell Health, Grand Rapids
Tracking Results of Ablations to Combat AF Registry Generation 2
RecruitingObservational study
- Corewell Health, Grand Rapids
Medtronic Terminate AF Study
Recruiting
- Corewell Health, Grand Rapids
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- Trinity Health Saint Mary's, Grand Rapids
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- New York City, NY21 studies
- Cleveland, OH17 studies
- Boston, MA17 studies
- Atlanta, GA16 studies
- Jonesboro, AR12 studies
- Chicago, IL12 studies
- Philadelphia, PA12 studies
- Ann Arbor, MI11 studies
- Cincinnati, OH10 studies
- Columbus, OH10 studies
- Pittsburgh, PA10 studies
- Austin, TX9 studies
Other studies in Grand Rapids
- Non-Small Cell Lung Cancer44 studies
- Colorectal Cancer40 studies
- Cancer (all types)28 studies
- Breast Cancer26 studies
- Ovarian Cancer24 studies
- Metastatic Cancer22 studies
- Prostate Cancer19 studies
- Endometrial Cancer18 studies
- Stomach Cancer18 studies
- Pancreatic Cancer18 studies
- Melanoma17 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.